Non classé
FDA okays Lilly's antibody treatment for Covid-19
The FDA has issued an emergency use authorization for Eli Lilly and Co’s monoclonal antibody therapy bamlanivimab to treat coronavirus infections in adults and children.
Source: SwissUXNews